Bilinsky Igor
SEC-identified person · CIK 1594604 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Lion Biotechnologies, Inc. N/A | Chief Operating Officer | filed 2021–2026 |
| Oncternal Therapeutics, Inc. ONCT | Chief Business Officer | filed 2019–2021 |
| Targeted Genetics Corp /WA/ TGEN.PK | Chief Operating Officer | filed 2017–2017 |
| Ignyta, Inc. RXDX | GM, Immuno-Oncology/SVP Sp Ops | filed 2015–2016 |
| Vical INC VICl | Sr VP, Corporate Development | filed 2013–2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.